Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
Y-Mabs Therapeutics (YMAB) Ownership Overview
24.00% Insiders
7.73% Mutual Funds
35.48% Other Institutional Investors
10.37% ETFs
22.42% Public Companies and
Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 53.58% of the company’s stock is owned by Institutional Investors, 24.00% is owned by Insiders, and 22.42% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 11, 2025 | Thomas Gad Cbo,director | xxxxxxxxxxxxx | $56536 |
| Mar 11, 2025 | Michael J Rossi President & Ceo,director | xxxxxxxxxxxxx | $20368 |
| Sep 17, 2024 | Thomas Gad Cbo,director | xxxxxxxxxxxxx | $1264650 |
| Aug 30, 2024 | Torben Lund Hansen Svp & Cto | xxxxxxxxxxxxx | $768500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,700,533 | Insider | 10.70% | 21,951,489 | |
| 2,761,825 | Insider | 6.30% | 12,897,723 | |
| 2,225,881 | Insider | 4.92% | 10,394,864 | |
| 1,844,398 | Institution | 4.08% | 8,613,339 | |
| 1,799,390 | Institution | 3.98% | 8,403,151 | |
| 1,540,964 | Institution | 3.41% | 7,196,302 | |
| 513,994 | Institution | 1.14% | 2,400,352 | |
| 406,660 | Institution | 0.90% | 1,899,102 | |
| 342,608 | Institution | 0.76% | 1,599,979 | |
| 330,402 | Insider | 0.73% | 1,542,977 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,540,964 | Institution | 3.41% | 7,196,302 | |
| 406,660 | Institution | 0.90% | 1,899,102 | |
| 342,608 | Institution | 0.76% | 1,599,979 | |
| 220,831 | Institution | 0.49% | 1,031,281 | |
| 209,716 | Institution | 0.46% | 979,374 | |
| 205,209 | Institution | 0.45% | 958,326 | |
| 101,877 | Institution | 0.23% | 475,766 | |
| 101,419 | Institution | 0.22% | 473,627 | |
| 49,900 | Institution | 0.11% | 233,033 | |
| 44,474 | Institution | 0.10% | 207,694 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,040,061 | Institution | 2.30% | 5,782,739 | |
| 988,211 | Institution | 2.19% | 4,614,945 | |
| 500,903 | Institution | 1.11% | 2,785,021 | |
| 431,045 | Institution | 0.95% | 2,038,843 | |
| 322,838 | Institution | 0.71% | 1,507,653 | |
| 225,860 | Institution | 0.50% | 1,054,766 | |
| 171,665 | Institution | 0.38% | 954,457 | |
| 155,135 | Institution | 0.34% | 733,789 | |
| 98,087 | Institution | 0.22% | 545,364 | |
| 84,713 | Institution | 0.19% | 395,610 |
FAQ
Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 35.48% of the company's stock is held by institutional investors, 24.00% is held by insiders, and 22.42% is held by retail investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.48% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.42% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
Johan Wedell-Wedellsborg owns the most shares of Y-Mabs Therapeutics (YMAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.